Viewing Study NCT06449833

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:46 AM
Ignite Modification Date: 2025-12-31 @ 5:40 PM
Study NCT ID: NCT06449833
Status: RECRUITING
Last Update Posted: 2024-06-10
First Post: 2024-04-15
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD
Sponsor: Zhujiang Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type2 Diabetes Mellitus View
None Nonalcoholic Fatty Liver Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Type 2 Diabetes Mellitus View
None Nonalcoholic fatty liver disease View
None Hepatic Fat Content View
None Henagliflozein View
None liver function View